Dare Bioscience, Inc. (DARE) stock
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Earnings
Dare Bioscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Dare Bioscience's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026after the close | $200.00K | – | -$0.20 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026after the close | $152.46K | – | -$0.20 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026after the close | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025after the close | $2.26K | -94.6% | -$0.28 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025after the close | -$21.17K | -194.4% | -$0.45 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024after the close | $41.69K | -95.8% | -$0.55 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024after the close | $22.44K | – | $1.52 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | $9.30K | – | -$0.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023before the open | $1.00M | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | – | – | -$0.10 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | -$0.09 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 30, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022after the close | – | – | -$0.08 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | $10.00M | – | $0.00 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022after the close | – | – | -$0.10 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 31, 2022before the open | – | – | – | Release |
| Q2 FY2019ended Jun 30, 2019 | Aug 14, 2019after the close | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 14, 2019after the close | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 13, 2018before the open | – | – | – | Filing |
| Q3 FY2016ended Sep 30, 2016 | Nov 3, 2016after the close | – | – | – | Filing |
| Q2 FY2016ended Jun 30, 2016 | Aug 4, 2016after the close | – | – | – | Filing |
| Q1 FY2016ended Mar 31, 2016 | May 2, 2016after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Dare Bioscience guided for has been reported
Guidance history
Every forecast Dare Bioscience put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Mar 28, 2024 | G&A expenses | FY2024 | $10.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Dare Bioscience filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- News
- Results
- Update
- Update
- Update
- Results
- Update
- Results
- Update
- Update
- Update
- Results
See a number that looks wrong?